Promising Therapeutic Strategies for Mesenchymal Stem Cell-Based Cardiovascular Regeneration: From Cell Priming to

Seung Taek Ji1, Hyunyun Kim1, Jisoo Yun1

  • 1Laboratory for Vascular Medicine and Stem Cell Biology, Convergence Stem Cell Research Center, Medical Research Institute, Pusan National University School of Medicine, Yangsan, Republic of Korea.

Insights

Mesenchymal stem cells (MSCs) show promise for cardiovascular regeneration but have low survival rates. Strategies like cell priming and tissue engineering aim to enhance MSC efficacy for treating ischemic cardiovascular diseases.

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Biology
  • Stem Cell Therapy

Background:

  • Ischemic cardiovascular diseases are a leading cause of death globally.
  • Adult stem cell therapies, particularly mesenchymal stem cells (MSCs), offer potential for cardiovascular regeneration due to their immunomodulatory and vascular repair capabilities.
  • A significant challenge for MSC therapy is their low survival rate in ischemic environments.

Purpose of the Study:

  • To review current clinical applications of MSCs in treating cardiovascular diseases.
  • To highlight strategies for enhancing MSC therapeutic efficacy for cardiovascular regeneration.
  • To explore cell priming and tissue engineering approaches for improving MSC survival and function.

Main Methods:

  • Review of current literature on MSC-based cardiovascular regeneration.
  • Analysis of strategies for improving MSC survival and longevity in vivo.
  • Examination of cell priming techniques and tissue engineering approaches (scaffolds, 3D printing).

Main Results:

  • Mesenchymal stem cells (MSCs) possess properties suitable for cardiovascular regeneration.
  • Low survival rates of engrafted MSCs in ischemic lesions remain a critical limitation.
  • Cell priming and advanced tissue engineering strategies show potential to overcome MSC limitations.

Conclusions:

  • Mesenchymal stem cells (MSCs) are promising for cardiovascular regeneration but require enhanced therapeutic strategies.
  • Priming MSCs and utilizing tissue engineering approaches like scaffolds and 3D printing can improve their efficacy.
  • Further development in these areas is crucial for advancing MSC-based treatments for ischemic cardiovascular diseases.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
6.3K